JP2016531151A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531151A5 JP2016531151A5 JP2016542319A JP2016542319A JP2016531151A5 JP 2016531151 A5 JP2016531151 A5 JP 2016531151A5 JP 2016542319 A JP2016542319 A JP 2016542319A JP 2016542319 A JP2016542319 A JP 2016542319A JP 2016531151 A5 JP2016531151 A5 JP 2016531151A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- coated tablet
- tablet according
- amount
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13184229.6 | 2013-09-13 | ||
| EP13184229.6A EP2848246A1 (en) | 2013-09-13 | 2013-09-13 | Pharmaceutical compositions containing refametinib |
| EP13184539.8 | 2013-09-16 | ||
| EP13184539 | 2013-09-16 | ||
| PCT/EP2014/069453 WO2015036512A1 (en) | 2013-09-13 | 2014-09-11 | Pharmaceutical compositions containing refametinib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016531151A JP2016531151A (ja) | 2016-10-06 |
| JP2016531151A5 true JP2016531151A5 (https=) | 2017-10-19 |
Family
ID=51541077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016542319A Pending JP2016531151A (ja) | 2013-09-13 | 2014-09-11 | レファメチニブを含有する医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160220494A1 (https=) |
| EP (1) | EP3043778B1 (https=) |
| JP (1) | JP2016531151A (https=) |
| CN (1) | CN105658209A (https=) |
| CA (1) | CA2923990A1 (https=) |
| DK (1) | DK3043778T3 (https=) |
| ES (1) | ES2648267T3 (https=) |
| HU (1) | HUE035877T2 (https=) |
| NO (1) | NO3043778T3 (https=) |
| PL (1) | PL3043778T3 (https=) |
| TW (1) | TW201542245A (https=) |
| UY (1) | UY35734A (https=) |
| WO (1) | WO2015036512A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10058630B2 (en) | 2012-10-22 | 2018-08-28 | Concievalve, Llc | Methods for inhibiting stenosis, obstruction, or calcification of a stented heart valve or bioprosthesis |
| EP2983790A2 (en) | 2013-04-09 | 2016-02-17 | Boston Biomedical, Inc. | Methods for treating cancer |
| SI3105218T1 (sl) | 2014-02-13 | 2019-11-29 | Incyte Corp | Ciklopropilamini kot inhibitorji LSD1 |
| MX373103B (es) | 2014-02-13 | 2020-04-17 | Incyte Holdings Corp | Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1). |
| WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
| EP3277689B1 (en) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
| LT3334709T (lt) | 2015-08-12 | 2025-03-10 | Incyte Holdings Corporation | Lsd1 inhibitoriaus druskos |
| AU2016333873A1 (en) | 2015-10-06 | 2018-05-17 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for treatment of metastatic and refractory cancers and tumors |
| CN107224438B (zh) * | 2016-03-25 | 2021-04-06 | 江苏豪森药业集团有限公司 | 富马酸沃诺拉赞药物组合物 |
| US20170332139A1 (en) * | 2016-05-10 | 2017-11-16 | Rovi Guides, Inc. | System and method for delivering missed portions of media assets to interested viewers |
| KR101796684B1 (ko) * | 2016-05-19 | 2017-11-10 | 건국대학교 산학협력단 | 케라틴 8 인산화 억제제를 포함하는 황반변성 예방 또는 치료용 약학 조성물 및 황반변성 치료제의 스크리닝 방법 |
| JP7106563B2 (ja) | 2016-11-29 | 2022-07-26 | スミトモ ファーマ オンコロジー， インコーポレイテッド | ナフトフラン誘導体、その調製、および使用方法 |
| CA3058162A1 (en) * | 2017-03-30 | 2018-10-04 | Boston Biomedical, Inc. | Compositions for treating and/or preventing cancer |
| CA3062656A1 (en) | 2017-05-17 | 2018-11-22 | Boston Biomedical, Inc. | Methods for treating cancer |
| JP7166754B2 (ja) * | 2017-11-22 | 2022-11-08 | 沢井製薬株式会社 | ダサチニブ無水物含有製剤 |
| WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
| CN115487186B (zh) * | 2022-09-29 | 2024-04-16 | 北京朗瑞邦科技有限公司 | 一种具有mTOR抑制活性的药物制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU225964B1 (en) * | 1994-07-12 | 2008-01-28 | Berwind Pharma Service | Moisture barrier film coating composition, method, and coated form |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| US6448323B1 (en) * | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
| SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
| PA8576201A1 (es) * | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
| JP2004051506A (ja) * | 2002-07-17 | 2004-02-19 | Nichiko Pharmaceutical Co Ltd | 経時的な変色を抑制した医薬組成物 |
| JP2004300138A (ja) * | 2003-03-18 | 2004-10-28 | Takeda Chem Ind Ltd | 安定化された経口固形製剤 |
| UA99731C2 (ru) * | 2007-07-30 | 2012-09-25 | Ардеа Биосайенсис, Инк | Кристаллические полиморфные формы n-(ариламино)сульфонамидов как ингибиторы мэк, композиция (варианты) и применение |
| US8808742B2 (en) * | 2008-04-14 | 2014-08-19 | Ardea Biosciences, Inc. | Compositions and methods for preparing and using same |
| DE102008059206A1 (de) * | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
| JP5767122B2 (ja) * | 2009-03-11 | 2015-08-19 | アルデア バイオサイエンシズ，インコーポレイティド | 特定の癌の治療のためのｒｄｅａ１１９／ｂａｙ８６９７６６を含む組み合わせ医薬 |
| JP2011162531A (ja) * | 2010-02-10 | 2011-08-25 | Takada Seiyaku Kk | フェキソフェナジン含有フイルムコーテイング経口製剤 |
| JP5700367B2 (ja) * | 2010-05-06 | 2015-04-15 | 高田製薬株式会社 | パロキセチン含有フイルムコ−テイング経口製剤 |
| WO2012120364A2 (en) * | 2011-03-09 | 2012-09-13 | Ideal Cures Pvt. Ltd. | Novel immediate release film coating compositions |
| UY35006A (es) * | 2012-09-06 | 2014-03-31 | Bayer Healthcare Llc | Composición farmacéutica recubierta que contiene regorafenib |
-
2014
- 2014-09-11 JP JP2016542319A patent/JP2016531151A/ja active Pending
- 2014-09-11 NO NO14766156A patent/NO3043778T3/no unknown
- 2014-09-11 HU HUE14766156A patent/HUE035877T2/en unknown
- 2014-09-11 WO PCT/EP2014/069453 patent/WO2015036512A1/en not_active Ceased
- 2014-09-11 PL PL14766156T patent/PL3043778T3/pl unknown
- 2014-09-11 DK DK14766156.5T patent/DK3043778T3/da active
- 2014-09-11 CA CA2923990A patent/CA2923990A1/en not_active Abandoned
- 2014-09-11 US US15/021,778 patent/US20160220494A1/en not_active Abandoned
- 2014-09-11 CN CN201480059238.XA patent/CN105658209A/zh active Pending
- 2014-09-11 EP EP14766156.5A patent/EP3043778B1/en not_active Not-in-force
- 2014-09-11 ES ES14766156.5T patent/ES2648267T3/es active Active
- 2014-09-12 UY UY0001035734A patent/UY35734A/es not_active Application Discontinuation
- 2014-09-12 TW TW103131660A patent/TW201542245A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016531151A5 (https=) | ||
| TWI415635B (zh) | 加衣錠片調製物及製備彼之方法 | |
| JP6666254B2 (ja) | アンドロゲン受容体アンタゴニストの固体医薬組成物 | |
| US20130216617A1 (en) | Pharmaceutical compositions of (r)-lansoprazole | |
| ES2435943T3 (es) | Formulaciones de vildagliptina | |
| US20170202819A1 (en) | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists | |
| JP2015107977A (ja) | 代謝型グルタミン酸５受容体（ｍＧｌｕ５）アンタゴニストの医薬組成物 | |
| CN108057036B (zh) | 一种egfr抑制剂的固体药物组合物 | |
| JPWO2003043661A1 (ja) | 酸に不安定な生理活性化合物を含有する製剤組成物及びその製法 | |
| WO2017103945A1 (en) | Pharmaceutical compositions | |
| US20220273619A1 (en) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolylglycyl-l-tyrosinate and methods for preparing the same | |
| EP3236952B1 (en) | Pharmaceutical tablet composition | |
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| US11576917B2 (en) | Pharmaceutical compositions comprising Ibrutinib | |
| US20200054659A1 (en) | Extended release capecitabine capsules | |
| US20160015646A1 (en) | Oral delivery system for sorafenib tosylate | |
| JP6739289B2 (ja) | ゲフィチニブを有効成分とする医薬錠剤の製造方法 | |
| JP6739275B2 (ja) | ゲフィチニブを有効成分とする医薬組成物 | |
| JP2020090456A (ja) | エルロチニブを有効成分とする医薬錠剤 | |
| WO2019194772A2 (en) | Modified release formulations of fesoterodine | |
| WO2022029798A1 (en) | Pharmaceutical compositions comprising ribociclib | |
| HK1251880A1 (zh) | 一种egfr抑制剂的固体药物组合物 | |
| JP6707471B2 (ja) | ピロールカルボキサミドの固形組成物 | |
| WO2024084496A1 (en) | Pharmaceutical compositions comprising acalabrutinib maleate | |
| EP1703900A1 (en) | Controlled release ketoprofen formulation |